View all newsletters
Receive our newsletter – data, insights and analysis delivered to you

Deal Trends in the Pharma Industry

Deals Insights dashboard tracks deal trends in the pharma industry. The dashboard provides an extensive analysis by capturing trends in terms of deal types, geographies, industry players, advisory firms, and the number of deals and their value.

In partnership with

Deals database provides comprehensive coverage across industries tracking market activity of different transaction types.

Pharma industry deal activity by deal type - volume (Last 12 months)

The chart below provides an insightful and thorough overview of deal activity in terms of deal types and the number of deals in the global pharma industry over the last 12 months. It covers mergers and acquisitions (M&As), private equity and venture financing deal types.

Pharma industry deal activity by deal type - value (Last 12 months)

The deals insights dashboard offers an analysis on deal activity in the global pharma industry in terms of deal type and value. Deal types encompassing M&As, private equity and venture financing are tracked over the last 12 months.

Mergers and acquisitions in the pharma industry

The deals insights dashboard provides an overview of M&A deal activity in the pharma industry. Besides M&A deals, the dashboard tracks the leading M&A financial and legal advisors, and M&A deal activity by theme.

Pharma industry M&A deal activity by region (Last 12 months)

The map below shows the M&A transactions recorded in the pharma industry in different regions in the last 12-month period.

Source: GlobalData

Largest M&A deals in the pharma industry

The following table lists details of the largest merger and acquisition deals in terms of value in the global pharma industry.

Acquirer Target Deal Date Value (US$m)
CSL Vifor Pharma 14 Dec 2021 12,300.0
Merck Acceleron Pharma 29 Sep 2021 11,500.0
Danaher Aldevron 17 Jun 2021 9,600.0
Pfizer Arena Pharmaceuticals 13 Dec 2021 6,700.0
PerkinElmer Biolegend 26 Jul 2021 5,250.0
Nenelite UDG Healthcare 12 May 2021 3,925.4
Healthcare of Ontario Pension Plan Greencross 07 Jun 2021 3,500.0
Biocon Biologics Viatris' Biosimilars Business 27 Feb 2022 3,335.0
Novo Nordisk Dicerna Pharmaceuticals 18 Nov 2021 3,300.0
Sanofi Translate Bio 03 Aug 2021 3,200.0
Source: GlobalData

M&A deals advisor rankings in the pharma industry (2021 vs. 2020)

The deals insights dashboard reveals top financial and legal advisors to M&A deals by both deal value and volume in the global pharma industry during 2020 and 2021.

M&A financial advisor rankings in the pharma industry

The deals insights dashboard compares rankings of leading financial advisors to M&A transactions in terms of deal value and volume between 2020 and 2021.

Advisor Name 2021 Rank 2020 Rank
The Goldman Sachs Group 1 2
Centerview Partners 2 1
J.P. Morgan Securities 3 12
Morgan Stanley 4 4
Bank of America 5 3
Barclays 6 16
Evercore 7 6
Guggenheim Partners 8 10
Credit Suisse Group 9 14
Citigroup 10 13
Source: GlobalData

The deals insights dashboard compares rankings of leading financial advisors to M&A transactions in terms of deal value and volume between 2020 and 2021, based on GlobalData’s Deals database.

Advisor Name 2021 Rank 2020 Rank
The Goldman Sachs Group 1 1
Centerview Partners 2 2
J.P. Morgan Securities 3 19
Morgan Stanley 4 6
Rothschild 5 7
SVB Financial Group 6 31
Jefferies 7 4
Cowen 8 8
JPMorgan Chase 9 9
Barclays 10 12
Source: GlobalData

M&A legal advisor rankings in the pharma industry

The deals insights dashboard compares rankings of leading legal advisors to M&A transactions in terms of deal value and volume between 2020 and 2021.

Advisor Name 2021 Rank 2020 Rank
Ropes & Gray 1 15
Simpson Thacher & Bartlett 2 48
Debevoise & Plimpton 3 50
Paul, Weiss, Rifkind, Wharton & Garrison 4 20
Kirkland & Ellis 5 11
Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates 6 10
Goodwin Procter 7 3
Cravath, Swaine & Moore 8 9
Fried, Frank, Harris, Shriver & Jacobson 9 1
Cooley 10 13
Source: GlobalData

The following table compares the rankings of leading legal advisors to M&A transactions in terms of deal value and volume between 2020 and 2021.

Advisor Name 2021 Rank 2020 Rank
Goodwin Procter 1 1
Cooley 2 2
Latham & Watkins 3 4
White & Case 4 6
Ropes & Gray 5 7
Kirkland & Ellis 6 10
Jones Day 7 14
Wilson Sonsini Goodrich & Rosati 8 5
Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates 9 8
Morgan, Lewis & Bockius 10 3
Source: GlobalData

M&A deal activity by theme in the pharma industry: Last 12 months (by volume)

The deals insights dashboard tracks the number of M&A deals by theme in the pharma industry based on GlobalData’s Deals database. The following chart lists top ten themes that hold the most number of deals.

Private equity deals in the pharma industry

The deals insights dashboard provides information on private equity deals data, including deals by region, top legal and financial advisors, and top deals by theme.

Private equity deal activity in the pharma industry by region (Last 12 months)

The map below shows the private equity deal activity in different regions of the globe over the last 12 months.

Source: GlobalData

Top private equity deals in the pharma industry

The following table lists details of the largest private equity deals by value in the global pharma industry.

Investor Target Deal Date Value (US$m)
EQT Partners Parexel International 02 Jul 2021 8,500.0
GIC Swedish Orphan Biovitrum 02 Sep 2021 8,047.6
Partners Group Pharmathen 19 Jul 2021 1,888.7
CBC Group Hugel 27 Aug 2021 1,500.0
Bain Capital Life Sciences EQRx 06 Aug 2021 1,200.0
Hillhouse Capital Group Genscript Biotech 14 May 2021 1,000.0
FountainVest Partners Beijing Zhendong Langdi Pharmaceutical 19 Nov 2021 900.0
TPG Sixth Street Partners Caris Life Sciences 11 May 2021 830.0
BGH Capital Virtus Health 14 Dec 2021 519.1
Altaris Capital Partners Johnson Matthey - Health business 17 Dec 2021 432.1
Source: GlobalData

Top private equity investors in the pharma industry (last 12 months)

The deals insights dashboard tracks top private equity investors in the pharma industry over the last 12 months.

Investor Name Value (US$m) No of Deals
RTW Investments 785.5 8
BVF Partners 1,737.5 6
GEM Global Yield LLC SCS 536.9 6
ArchiMed 34.8 6
Rock Springs Capital Management 2,380.0 5
Casdin Capital 860.0 4
EcoR1 Capital 278.0 4
HBM Healthcare Investments 141.9 4
BroadOak Capital Partners 20.0 4
Bain Capital Life Sciences 1,670.0 3
Source: GlobalData

Private equity deals advisors in the pharma industry (2021 vs. 2020)

The deals insights dashboard monitors financial and legal advisors to private equity deals by value and volume in the global pharma industry during 2020 and 2021.

Private equity financial advisor rankings in the pharma industry

The following table compares rankings of leading financial advisors to private equity transactions in terms of value and volume between 2020 and 2021.

Advisor Name 2021 Rank 2020 Rank
Evercore 1 8
Morgan Stanley 2 18
Jefferies 3 6
The Goldman Sachs Group 4 9
Barclays 5 16
UBS Group 6 46
Rothschild 7 1
J.P. Morgan Securities 8 36
Lazard 9 50
Bank of America 10 19
Source: GlobalData

The deals insights dashboard compares ranking of leading financial advisors to private equity transactions in terms of value and volume between 2020 and 2021.

Advisor Name 2021 Rank 2020 Rank
Jefferies 1 1
Rothschild 2 5
Cowen 3 3
SVB Financial Group 4 2
WBC Holdings 5 10
Morgan Stanley 6 16
J.P. Morgan Securities 7 44
Cantor Fitzgerald 8 17
Stifel Financial 9 18
The Goldman Sachs Group 10 19
Source: GlobalData

Private equity legal advisor rankings in the pharma industry

The deals insights dashboard compares ranking of leading legal advisors to private equity transactions in terms of value and volume between 2020 and 2021.

Advisor Name 2021 Rank 2020 Rank
Uria Menendez Abogados SLP 1 3
Weil, Gotshal & Manges 2 35
Kirkland & Ellis 3 24
Linklaters 4 7
Latham & Watkins 5 1
Simpson Thacher & Bartlett 6 12
Sullivan & Cromwell 7 50
Mannheimer Swartling Advokatbyra 8 37
Ropes & Gray 9 2
Cleary Gottlieb Steen & Hamilton 10 25
Source: GlobalData

The deals insights dashboard compares ranking of leading legal advisors to private equity transactions in terms of value and volume between 2020 and 2021.

Advisor Name 2021 Rank 2020 Rank
Goodwin Procter 1 2
Kirkland & Ellis 2 4
Ropes & Gray 3 5
Latham & Watkins 4 1
McDermott Will & Emery 5 13
Jones Day 6 10
White & Case 7 20
Cooley 8 21
Gibson, Dunn & Crutcher 9 22
Linklaters 10 23
Source: GlobalData

Private equity deals by theme in the pharma industry: Last 12 months (by volume)

The deals insights dashboard tracks the number of private equity deals by theme in the pharma industry based on GlobalData’s Deals database. The following chart lists top ten themes that hold the most number of deals in 2021.

Banner

Venture financing deals in the pharma industry

The deals insights dashboard provides an overview of venture financing deal activity in the pharma industry around the globe, including deals by region, top venture financing deals and capital investors.

Venture financing deal activity in the pharma industry by region (Last 12 months)

The deals insights dashboard tracks venture financing deals recorded in the pharma industry in different regions of the globe in the last 12-month period.

Source: GlobalData

Top ten venture financing deals in the pharma industry

The following table lists the top ten venture financing deals by value in the global pharma industry.

Investor Target Deal Date Value (US$m)
Gaorong Capital Suzhou Abogen Biosciences 19 Aug 2021 700.0
Harel Insurance Investments and Financial Services Eikon Therapeutics 06 Jan 2022 517.8
Scottish Enterprise Kynos Therapeutics 03 Feb 2022 506.6
Canada Pension Plan Investment Board Laronde 30 Aug 2021 440.0
Sino Biopharmaceutical XtalPi 11 Aug 2021 400.0
Catalio Capital Management Neumora Therapeutics 07 Oct 2021 400.0
Alaska Permanent Fund Generate Biomedicines 18 Nov 2021 370.0
IMO Ventures Suzhou Abogen Biosciences 29 Nov 2021 300.0
SoftBank Vision Fund Tessera Therapeutics 19 Apr 2022 300.0
Undisclosed Vyripharm Enterprises 13 Oct 2021 300.0
Source: GlobalData

Top venture capital investors in the pharma industry (Last 12 months)

The deals insights dashboard tracks top venture capital investors in the pharma industry over the last 12 months.

Investor Name Value (US$m) No of Deals
Alexandria Venture Investments 3,683.2 48
RA Capital Management 4,081.3 45
Orbimed Advisors 3,520.4 39
Casdin Capital 3,226.2 29
Lilly Asia ventures 3,018.9 27
Cormorant Asset Management 2,638.5 25
Logos Global Management 2,824.6 24
Sequoia Capital China 1,604.3 23
Samsara BioCapital 2,235.0 21
Northpond Ventures 1,109.0 21
Source: GlobalData

Venture financing deal activity by theme in the pharma industry: Last 12 months (by volume)

The chart below gives information about the number of venture financing deals by theme in the global pharma industry. The following chart lists top ten themes that hold the most number of deals in 2021.

All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.

Latest News

View More
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU